Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON36448Recruiting
Open-label trial of methylphenidate and fluoxetine in attention deficit hyperactivity disorder (ADHD), major depressive disorder (MDD) and anxiety disorder (6 arms), sponsored by Radiologie Holding. Primary endpoints: phMRI cerebral perfusion response, Diffusion tensor imaging metrics and 1 more. Started May 2011; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON36448.